FSSNX
Price
$37.53
Change
-$0.51 (-1.34%)
Updated
Aug 20 closing price
Net Assets
34.07B
OSCCX
Price
$23.40
Change
+$0.18 (+0.78%)
Updated
Aug 21 closing price
Net Assets
2.63B
Interact to see
Advertisement

FSSNX vs OSCCX

FSSNX vs OSCCX Comparison Chart in %
View a ticker or compare two or three
VS
FSSNX vs. OSCCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and OSCCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 34.1B vs. OSCCX (2.63B). FSSNX pays higher dividends than OSCCX: FSSNX (1.06) vs OSCCX (0.30). FSSNX was incepted earlier than OSCCX: FSSNX (15 years) vs OSCCX (13 years). OSCCX (1.80) is less costly to investors than FSSNX (0.03). OSCCX is a more actively managed with annual turnover of: 53.00 vs. FSSNX (14.00). FSSNX has a lower initial minimum investment than OSCCX: FSSNX (0) vs OSCCX (1000). FSSNX annual gain was more profitable for investors over the last year : 33.33 vs. OSCCX (13.86). FSSNX return over 5 years is better than : 44.88 vs. OSCCX (19.17).
FSSNXOSCCXFSSNX / OSCCX
Total Expense Ratio0.031.801%
Annual Report Gross Expense Ratio0.031.801%
Fund Existence15 years13 years-
Gain YTD21.50918.601116%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets34.1B2.63B1,295%
Annual Yield % from dividends1.060.30357%
Returns for 1 year33.3313.86241%
Returns for 3 years68.9534.63199%
Returns for 5 years44.8819.17234%
Returns for 10 years142.2486.32165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI165.732.35
+1.44%
State Street® SPDR® S&P® Biotech ETF
HQL22.380.30
+1.36%
abrdn Life Sciences Investors
FMED32.530.42
+1.30%
Fidelity Disruptive Medicine ETF
IDVZ34.910.28
+0.80%
Polen International Div Inc ETF
RHTX20.30N/A
N/A
RH Tactical Outlook ETF